Correlation Between MEDIPOST and Ubiquoss
Can any of the company-specific risk be diversified away by investing in both MEDIPOST and Ubiquoss at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MEDIPOST and Ubiquoss into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MEDIPOST Co and Ubiquoss, you can compare the effects of market volatilities on MEDIPOST and Ubiquoss and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MEDIPOST with a short position of Ubiquoss. Check out your portfolio center. Please also check ongoing floating volatility patterns of MEDIPOST and Ubiquoss.
Diversification Opportunities for MEDIPOST and Ubiquoss
Excellent diversification
The 3 months correlation between MEDIPOST and Ubiquoss is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding MEDIPOST Co and Ubiquoss in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ubiquoss and MEDIPOST is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MEDIPOST Co are associated (or correlated) with Ubiquoss. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ubiquoss has no effect on the direction of MEDIPOST i.e., MEDIPOST and Ubiquoss go up and down completely randomly.
Pair Corralation between MEDIPOST and Ubiquoss
Assuming the 90 days trading horizon MEDIPOST Co is expected to generate 3.67 times more return on investment than Ubiquoss. However, MEDIPOST is 3.67 times more volatile than Ubiquoss. It trades about 0.21 of its potential returns per unit of risk. Ubiquoss is currently generating about -0.03 per unit of risk. If you would invest 581,000 in MEDIPOST Co on September 27, 2024 and sell it today you would earn a total of 585,000 from holding MEDIPOST Co or generate 100.69% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
MEDIPOST Co vs. Ubiquoss
Performance |
Timeline |
MEDIPOST |
Ubiquoss |
MEDIPOST and Ubiquoss Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with MEDIPOST and Ubiquoss
The main advantage of trading using opposite MEDIPOST and Ubiquoss positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MEDIPOST position performs unexpectedly, Ubiquoss can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ubiquoss will offset losses from the drop in Ubiquoss' long position.The idea behind MEDIPOST Co and Ubiquoss pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Ubiquoss vs. Samsung Electronics Co | Ubiquoss vs. Samsung Electronics Co | Ubiquoss vs. LG Energy Solution | Ubiquoss vs. SK Hynix |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |